Defatting of donor transplant livers during normothermic perfusion - a randomised clinical trial: study protocol for the DeFat study
<p><strong>Background:</strong> Liver disease is the third leading cause of premature death in the UK. Transplantation is the only successful treatment for end-stage liver disease but is limited by a shortage of suitable donor organs. As a result, up to 20% of patients on liver tra...
| Главные авторы: | , , , , , , |
|---|---|
| Формат: | Journal article |
| Язык: | English |
| Опубликовано: |
BioMed Central
2024
|